Literature DB >> 15543478

Genetic and molecular aspects of hypospadias.

B Utsch1, N Albers, M Ludwig.   

Abstract

Hypospadias, a midline fusion defect of the male ventral urethra, is a relatively common genital anomaly occurring in 0.3 - 7 of 1000 live male births. The anatomical location of the misplaced urethral meatus determines the severity of this anomaly with the severity increasing from distal to proximal. Glandular and penile hypospadias, the most common forms, often appear as an isolated anomaly and account for the majority of hypospadias, whereas about 20 % are classified as scrotal and perineal types. These latter forms frequently occur in association with other genital anomalies such as microphallus, bifid scrotum, penoscrotal transposition, and cryptorchidism, and may represent an intersex phenotype. Besides a higher incidence in consanguineous families and a suggested recessive inheritance, in other families a dominant transmission is likely. The recurrence risk in the next generation seems to be correlated with the severity of hypospadias. Only 30 % of severe hypospadias can be attributed to defects in the synthesis of testosterone or adrenal steroid hormones, receptor defects, syndrome-associated hypospadias, chromosomal anomalies, defects in other genetic factors, or exogenous forms. To identify the underlying causes of the remaining 70 % "idiopathic" hypospadias, familial and twin studies were performed. Familial studies can help identify gene loci and, subsequently, candidate genes by mutational analysis. Either linkage analysis in large families with many affected individuals suspicious for a monogenic trait or association studies in cases of a complex inheritance in many families with a few affected individuals can be performed. Microarrays and proteomics can help detect gene expression or protein differences. Furthermore, genetically modified animal models can be used to detect phylogenetically homologous genes in man. In addition to an optimal documentation and acquisition of blood and tissue samples this requires a close cooperation between clinicians in the operative and non-operative specialties as well as geneticists.

Entities:  

Mesh:

Year:  2004        PMID: 15543478     DOI: 10.1055/s-2004-821275

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  7 in total

Review 1.  [Genetic and molecular biological aspects of the bladder exstrophy-epispadias complex (BEEC)].

Authors:  M Ludwig; B Utsch; H Reutter
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

2.  Is activating transcription factor 3 up-regulated in patients with hypospadias?

Authors:  Cenk Gurbuz; Selamettin Demir; Ebru Zemheri; Lutfi Canat; Mert Kilic; Turhan Caskurlu
Journal:  Korean J Urol       Date:  2010-08-18

3.  Frizzled 1 and frizzled 2 genes function in palate, ventricular septum and neural tube closure: general implications for tissue fusion processes.

Authors:  Huimin Yu; Philip M Smallwood; Yanshu Wang; Roman Vidaltamayo; Randall Reed; Jeremy Nathans
Journal:  Development       Date:  2010-11       Impact factor: 6.868

4.  Detection and incidence of anomalies associated with hypospadias.

Authors:  Tal Friedman; Avshalom Shalom; Guy Hoshen; Shlomo Brodovsky; Martin Tieder; Melvyn Westreich
Journal:  Pediatr Nephrol       Date:  2008-06-24       Impact factor: 3.714

5.  A Proteomics Signature of Mild Hypospadias: A Pilot Study.

Authors:  Coriness Piñeyro-Ruiz; Horacio Serrano; Inmaculada Jorge; Eric Miranda-Valentin; Marcos R Pérez-Brayfield; Emilio Camafeita; Raquel Mesa; Jesús Vázquez; Juan Carlos Jorge
Journal:  Front Pediatr       Date:  2020-12-23       Impact factor: 3.418

6.  Ultrasonographic Diagnosis of Fetal Hypospadias.

Authors:  Kim-Seng Law
Journal:  Diagnostics (Basel)       Date:  2022-03-22

7.  Twenty-Four Genes are Upregulated in Patients with Hypospadias.

Authors:  R Karabulut; Z Turkyilmaz; K Sonmez; G Kumas; Sg Ergun; Ma Ergun; Ac Basaklar
Journal:  Balkan J Med Genet       Date:  2013-12       Impact factor: 0.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.